2-氯-4-(1H-吡唑-3-基)苯甲腈 、 N-Boc-(R)-(+)-2-氨基-1-丁醇 以0.249 g (31%) of the title compound was obtained after workup的产率得到(R)-4-(1-(2-aminobutyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile hydrochloride
The present disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts thereof. The present disclosure also relates to compositions and methods of treating comprising compounds of formula (I), and pharmaceutically acceptable salts thereof.